David P. Schenkein, Director at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 32,726 shares at $22.85 ($748K) on 2023-04-03, disclosed to the SEC on 2023-04-05.
Scheduled sale ($748k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.85 | 16,363 | $374K | 50.0% |
| 2 | $22.85 | 16,363 | $374K | 50.0% |
| Total | $22.85 avg | 32,726 | $748K | 100% |
| Filing → |
| AGIO | SELL | 2024-02-27 | $4.5M | — | Filing → |
| AGIO | SELL | 2023-03-29 | $443K | — | Filing → |
| AGIO | SELL | 2023-03-15 | $862K | — | Filing → |